Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10473238rdf:typepubmed:Citationlld:pubmed
pubmed-article:10473238lifeskim:mentionsumls-concept:C0038897lld:lifeskim
pubmed-article:10473238lifeskim:mentionsumls-concept:C0007561lld:lifeskim
pubmed-article:10473238lifeskim:mentionsumls-concept:C0042313lld:lifeskim
pubmed-article:10473238lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:10473238pubmed:issue2lld:pubmed
pubmed-article:10473238pubmed:dateCreated2000-2-10lld:pubmed
pubmed-article:10473238pubmed:abstractTextThe efficacy of antibiotic prophylaxis in cardiac surgery was compared between 97 patients receiving a single 2 g dosage of ceftriaxone and 103 receiving 500 mg of vancomycin i.v. every 6 h for 48 h. The overall infection rate was 13.4% in the ceftriaxone and 10.7% in the vancomycin group. Four (4%) wound infections, including one mediastinitis, occurred in the ceftriaxone group and five (5%) in the vancomycin group, with no statistically significant difference. The findings of this study support the adequacy of a simple single dose of ceftriaxone prophylaxis in cardiac surgery, at least in hospitals with low incidence of vancomycin-resistant staphylococcal infections.lld:pubmed
pubmed-article:10473238pubmed:languageenglld:pubmed
pubmed-article:10473238pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473238pubmed:citationSubsetIMlld:pubmed
pubmed-article:10473238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473238pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10473238pubmed:statusMEDLINElld:pubmed
pubmed-article:10473238pubmed:monthAuglld:pubmed
pubmed-article:10473238pubmed:issn0305-7453lld:pubmed
pubmed-article:10473238pubmed:authorpubmed-author:ValtonenV VVVlld:pubmed
pubmed-article:10473238pubmed:authorpubmed-author:HarjulaA LALlld:pubmed
pubmed-article:10473238pubmed:authorpubmed-author:SalminenU SUSlld:pubmed
pubmed-article:10473238pubmed:authorpubmed-author:ViljanenT UTUlld:pubmed
pubmed-article:10473238pubmed:authorpubmed-author:IkonenT ETElld:pubmed
pubmed-article:10473238pubmed:authorpubmed-author:SahlmanA EAElld:pubmed
pubmed-article:10473238pubmed:issnTypePrintlld:pubmed
pubmed-article:10473238pubmed:volume44lld:pubmed
pubmed-article:10473238pubmed:ownerNLMlld:pubmed
pubmed-article:10473238pubmed:authorsCompleteYlld:pubmed
pubmed-article:10473238pubmed:pagination287-90lld:pubmed
pubmed-article:10473238pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:meshHeadingpubmed-meshheading:10473238...lld:pubmed
pubmed-article:10473238pubmed:year1999lld:pubmed
pubmed-article:10473238pubmed:articleTitleCeftriaxone versus vancomycin prophylaxis in cardiovascular surgery.lld:pubmed
pubmed-article:10473238pubmed:affiliationThe Deaconess Hospital in Helsinki, Finland. ulla.s.salminen@netsonic.filld:pubmed
pubmed-article:10473238pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10473238pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10473238pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10473238pubmed:publicationTypeRandomized Controlled Triallld:pubmed